- Home
- MLTX vs GTX Comparison
MLTX vs GTX Comparison
Compare MLTX & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLTX
- GTX
- Stock Information
- Founded
- MLTX 2021
- GTX 2018
- Country
- MLTX Switzerland
- GTX Switzerland
- Employees
- MLTX N/A
- GTX N/A
- Industry
- MLTX Biotechnology: Pharmaceutical Preparations
- GTX Auto Parts:O.E.M.
- Sector
- MLTX Health Care
- GTX Consumer Discretionary
- Exchange
- MLTX Nasdaq
- GTX Nasdaq
- Market Cap
- MLTX 2.8B
- GTX 2.6B
- IPO Year
- MLTX N/A
- GTX N/A
- Fundamental
- Price
- MLTX $55.75
- GTX $12.99
- Analyst Decision
- MLTX Strong Buy
- GTX Strong Buy
- Analyst Count
- MLTX 7
- GTX 1
- Target Price
- MLTX $74.83
- GTX $14.00
- AVG Volume (30 Days)
- MLTX 380.3K
- GTX 3.7M
- Earning Date
- MLTX 08-05-2025
- GTX 10-23-2025
- Dividend Yield
- MLTX N/A
- GTX 1.85%
- EPS Growth
- MLTX N/A
- GTX 42.92
- EPS
- MLTX N/A
- GTX 1.43
- Revenue
- MLTX N/A
- GTX $3,461,000,000.00
- Revenue This Year
- MLTX N/A
- GTX $2.10
- Revenue Next Year
- MLTX N/A
- GTX $0.23
- P/E Ratio
- MLTX N/A
- GTX $9.11
- Revenue Growth
- MLTX N/A
- GTX N/A
- 52 Week Low
- MLTX $31.42
- GTX $7.02
- 52 Week High
- MLTX $58.26
- GTX $13.52
- Technical
- Relative Strength Index (RSI)
- MLTX 59.35
- GTX 58.24
- Support Level
- MLTX $53.29
- GTX $12.44
- Resistance Level
- MLTX $56.78
- GTX $13.40
- Average True Range (ATR)
- MLTX 2.07
- GTX 0.30
- MACD
- MLTX -0.05
- GTX -0.05
- Stochastic Oscillator
- MLTX 78.36
- GTX 51.16
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.